These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management. Racz H; Mehta S J Rheumatol; 2006 Sep; 33(9):1723-5. PubMed ID: 16960934 [No Abstract] [Full Text] [Related]
4. [Lung involvement in systemic sclerosis]. Posa M; Stelle M; Lador F; Chizzolini C Rev Med Suisse; 2015 Apr; 11(469):802-6. PubMed ID: 26040160 [TBL] [Abstract][Full Text] [Related]
9. Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA. Sankar S; Habib M; Jaafar S; Nagaraja V; Roofeh D; Young A; Huang S; Khanna D Clin Exp Rheumatol; 2021; 39 Suppl 131(4):43-51. PubMed ID: 33734968 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort. Vemulapalli S; Cohen L; Hsu V Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary hypertension in systemic sclerosis: different phenotypes. Launay D; Sobanski V; Hachulla E; Humbert M Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954767 [TBL] [Abstract][Full Text] [Related]